The DOI matches its Crossref record.
A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 40
- Bailey, 1991, Interaction of citrus juices with felodipine and nifedipine, Lancet, 337, 268, 10.1016/0140-6736(91)90872-M · DOI · Paper page
- Bailey, 1998, Grapefruit juice-drug interactions, Br J Clin Pharmacol, 46, 101, 10.1046/j.1365-2125.1998.00764.x · DOI · Paper page
- Wilkinson, 2005, Drug metabolism and variability among patients in drug response, N Engl J Med, 352, 2211, 10.1056/NEJMra032424 · DOI · Paper page
- Watkins, 1987, Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man, J Clin Invest, 80, 1029, 10.1172/JCI113156 · DOI · Paper page
- Paine, 1997, Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism, J Pharmacol Exp Ther, 283, 1552, 10.1016/S0022-3565(24)37149-6 · DOI · Paper page
- Lown, 1997, Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression, J Clin Invest, 99, 2545, 10.1172/JCI119439 · DOI · Paper page
- Huang, 2004, Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?, J Clin Pharmacol, 44, 559, 10.1177/0091270004265367 · DOI
- Schmiedlin-Ren, 1997, Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins, Drug Metab Dispos, 25, 1228
- Fukuda, 2000, Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction, J Chromatogr B Biomed Sci Appl, 741, 195, 10.1016/S0378-4347(00)00104-3 · doi:10.1016/s0378-4347(00)00104-3
- Miniscalco, 1992, Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice, J Pharmacol Exp Ther, 261, 1195, 10.1016/S0022-3565(25)11138-5 · DOI · Paper page
- Bailey, 1993, Grapefruit juice–felodipine interaction: mechanism, predictability, and effect of naringin, Clin Pharmacol Ther, 53, 637, 10.1038/clpt.1993.84 · DOI · Paper page
- Bailey, 1993, Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics, Clin Pharmacol Ther, 54, 589, 10.1038/clpt.1993.195 · DOI · Paper page
- Rashid, 1993, Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice, Br J Clin Pharmacol, 36, 460, 10.1111/j.1365-2125.1993.tb00396.x · DOI
- He, 1998, Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice, Chem Res Toxicol, 11, 252, 10.1021/tx970192k · DOI
- Guo, 2000, Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity, Drug Metab Dispos, 28, 766, 10.1016/S0090-9556(24)15346-9 · doi:10.1016/s0090-9556(24)15346-9
- Tassaneeyakul, 2000, Inhibition selectivity of grapefruit juice components on human cytochromes P450, Arch Biochem Biophys, 378, 356, 10.1006/abbi.2000.1835 · DOI · Paper page
- Paine, 2004, Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties, Drug Metab Dispos, 32, 1146, 10.1124/dmd.104.000547 · DOI
- Paine, 2005, Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition, J Pharmacol Exp Ther, 312, 1151, 10.1124/jpet.104.076836 · doi:10.1124/jpet.104.076836
- Bailey, 1998, Grapefruit juice-felodipine interaction: effect of naringin and 6,7-dihydroxybergamottin in humans, Clin Pharmacol Ther, 64, 248, 10.1016/S0009-9236(98)90173-4 · DOI
- Kakar, 2004, 67-Dihydroxybergamottin contributes to the grapefruit juice effect, Clin Pharmacol Ther, 75, 569, 10.1016/j.clpt.2004.02.007 · doi:10.1016/j.clpt.2004.02.007
- Schmiedlin-Ren, 1997, Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1α,25-dihydroxyvitamin D3, Mol Pharmacol, 51, 741, 10.1124/mol.51.5.741 · DOI · Paper page
- Mouly, 2004, Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir, J Pharmacol Exp Ther, 308, 941, 10.1124/jpet.103.056390 · DOI
- Widmer, 2000, Determination of naringin and neohesperidin in orange juice by liquid chromatography with UV detection to detect the presence of grapefruit juice: collaborative study, J AOAC Int, 83, 1155, 10.1093/jaoac/83.5.1155 · doi:10.1093/jaoac/83.5.1155
- Widmer, 2005, Variation in furanocoumarin content and new furanocoumarin dimers in commercial grapefruit (Citrus paradisi Macf.) juices, J Food Sci, 70, C307, 10.1111/j.1365-2621.2005.tb07178.x · DOI
- Kimball, 1990, Processing effects during commercial debittering of California navel orange juice, J Agric Food Chem, 38, 1396, 10.1021/jf00096a021 · doi:10.1021/jf00096a021
- Fukuda, 1997, Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction, Pharmacogenetics, 7, 391, 10.1097/00008571-199710000-00008 · doi:10.1097/00008571-199710000-00008
- Bailey, 2003, Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice, Clin Pharmacol Ther, 73, 529, 10.1016/S0009-9236(03)00051-1 · DOI
- Goosen, 2004, Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans, Clin Pharmacol Ther, 76, 607, 10.1016/j.clpt.2004.08.019 · doi:10.1016/j.clpt.2004.08.019
- Spahn-Langguth, 2001, Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol, Eur J Pharmacol Sci, 12, 361, 10.1016/S0928-0987(00)00191-3 · DOI
- Dresser, 2002, Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine, Clin Pharmacol Ther, 71, 11, 10.1067/mcp.2002.121152 · DOI · Paper page
- Xu, 2003, Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: lime, lemon, grapefruit, and pummelo, Pharm Res, 20, 169, 10.1023/A:1022254617664 · DOI
- Takanaga, 1998, Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells, Biol Pharm Bull, 21, 1062, 10.1248/bpb.21.1062 · DOI · Paper page
- Ohnishi, 2000, Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P4503A4, Br J Pharmacol, 130, 1369, 10.1038/sj.bjp.0703433 · DOI · Paper page
- Honda, 2004, Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux, Br J Pharmacol, 143, 856, 10.1038/sj.bjp.0706008 · DOI
- Becquemont, 2001, Effect of grapefruit juice on digoxin pharmacokinetics in humans, Clin Pharmacol Ther, 70, 311, 10.1016/S0009-9236(01)13478-8 · doi:10.1016/s0009-9236(01)13478-8
- Parker, 2003, Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans, Pharmacotherapy, 23, 979, 10.1592/phco.23.8.979.32881 · doi:10.1592/phco.23.8.979.32881
- Schwarz, 2005, Grapefruit juice ingestion significantly reduces talinolol bioavailability, Clin Pharmacol Ther, 77, 291, 10.1016/j.clpt.2004.11.111 · DOI
- Lilja, 2003, Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol, Clin Pharmacol Ther, 73, 192, 10.1067/mcp.2003.26 · DOI
- Kobayashi, 2003, Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane, J Pharmacol Exp Ther, 306, 703, 10.1124/jpet.103.051300 · DOI · Paper page
- Satoh, 2005, Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B, Drug Metab Dispos, 33, 518, 10.1124/dmd.104.002337 · DOI · Paper page
Cited by
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Isothiocyanate from Broccoli, Sulforaphane, and Its Properties
Vanduchova, A., Anzenbacher, P., & Anzenbacherova, E. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2018.0024 · Cited by 322
Bailey, D. G., Dresser, G. K., Leake, B. F., & Kim, R. B. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100104 · Cited by 287
Drug-grapefruit juice interactions
Pirmohamed, M. (2013) · BMJ · doi:10.1136/bmj.f1 · Cited by 140
Dumitru, C. N., Marcu, T., Dumitru, A. O., Tudor, S. S., Ferțu, I. D., Elisei, A.-M., & Goroftei, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081313 · Cited by 2
“The historical benchmark of food–drug interactions remains grapefruit juice, whose furanocoumarins irreversibly inhibit intestinal CYP3A4 and increase exposure to numerous drugs [8–10].”
Metadata
- Authors
- Paine, M. F., Widmer, W. W., Hart, H. L., Pusek, S. N., Beavers, K. L., Criss, A. B., Brown, S. S., Thomas, B. F., & Watkins, P. B.
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 83
- Issue
- 5
- Pages
- 1097-1105
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2161349247
- Cited by
- 160
- References
- 0
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Update notices
- erratum (2006-07-01)
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6152 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction. https://app.cochat.ai/papers/10.1093/ajcn/83.5.1097
- The paper
- Paine, M. F., Widmer, W. W., Hart, H. L., Pusek, S. N., Beavers, K. L., Criss, A. B., Brown, S. S., Thomas, B. F., & Watkins, P. B. (2006). A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/83.5.1097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.